Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia
- Conditions
- Interventions
- First Posted Date
- 2006-01-11
- Last Posted Date
- 2018-05-11
- Lead Sponsor
- German CLL Study Group
- Target Recruit Count
- 169
- Registration Number
- NCT00275015
- Locations
- π©πͺ
Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin, Berlin, Germany
π©πͺRobert Roessle Comprehensive Cancer Center at University of Berlin - Charite Campus Buch, Berlin, Germany
π©πͺInternistische Praxis - Trier, Trier, Germany
Bendamustine and Rituximab in Treating Patients With Previously Untreated or Relapsed Chronic Lymphocytic Leukemia
- Conditions
- Interventions
- First Posted Date
- 2006-01-11
- Last Posted Date
- 2019-05-23
- Lead Sponsor
- German CLL Study Group
- Target Recruit Count
- 195
- Registration Number
- NCT00274989
- Locations
- π©πͺ
HELIOS Klinikum Bad Saarow, Bad Saarow, Germany
π©πͺInternistische Praxis - Arnstadt, Arnstadt, Germany
π©πͺKlinikum Augsburg, Augsburg, Germany
Rituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
- Conditions
- Interventions
- First Posted Date
- 2006-01-11
- Last Posted Date
- 2019-05-23
- Lead Sponsor
- German CLL Study Group
- Target Recruit Count
- 825
- Registration Number
- NCT00275054
- Locations
- π¦πΉ
Universitaetsklinik fuer Innere Medizin I, Vienna, Austria
π«π·CHU Poitiers, Poitiers, France
π©πͺSt. Hedwig Krankenhaus, Berlin, Germany
Fludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
- First Posted Date
- 2005-12-07
- Last Posted Date
- 2020-02-20
- Lead Sponsor
- German CLL Study Group
- Target Recruit Count
- 877
- Registration Number
- NCT00262782
- Locations
- π©πͺ
Internistische Praxis - Neuenkirchen, Neuenkirchen, Germany
π©πͺKlinikum St. Marien, Amberg, Germany
π©πͺInternistische Praxis - Arnstadt, Arnstadt, Germany
Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
- Conditions
- Interventions
- First Posted Date
- 2005-12-07
- Last Posted Date
- 2019-05-23
- Lead Sponsor
- German CLL Study Group
- Target Recruit Count
- 206
- Registration Number
- NCT00262795
- Locations
- π©πͺ
Onkologische Schwerpunktpraxis, Cottbus, Germany
π¦πΉHanuschkrankenhaus, Vienna, Austria
π©πͺSaint Josef - Hospital Bochum, Bochum, Germany
Fludarabine, Cyclophosphamide, and Alemtuzumab in Patients With B-cell Chronic Lymphatic Leukemia (B-CLL)
- First Posted Date
- 2005-09-07
- Last Posted Date
- 2016-10-03
- Lead Sponsor
- German CLL Study Group
- Target Recruit Count
- 61
- Registration Number
- NCT00147901
- Locations
- π©πͺ
University of Cologne, Cologne, NRW, Germany